We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+12.91%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$4.92B
AUM Growth
+$1.62B
Cap. Flow
+$1.41B
Cap. Flow %
28.67%
Top 10 Hldgs %
36.75%
Holding
1,419
New
468
Increased
176
Reduced
163
Closed
410

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$208M
2
AMZN icon
Amazon
AMZN
+$165M
3
AMD icon
Advanced Micro Devices
AMD
+$86.9M
4
XYZ
Block Inc
XYZ
+$33.2M
5
ROKU icon
Roku
ROKU
+$27M

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$10.3M
2
MRNA icon
Moderna
MRNA
+$9.79M
3
JD icon
JD.com
JD
+$6.14M
4
AZN icon
AstraZeneca
AZN
+$5.27M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.32M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 8.5%
2 Technology 4.33%
3 Communication Services 2.49%
4 Healthcare 1.87%
5 Financials 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSTM icon
626
Constellium
CSTM
$3.76B
$493K 0.01%
+27,500
New +$505K
CMRC
627
CALL
Commerce.com Inc Series 1
CMRC
$272M
$492K 0.01%
+13,900
New +$654K
KURA icon
628
PUT
Kura Oncology
KURA
$793M
$490K 0.01%
35,000
+20,000
+133% +$324K
CHTR icon
629
Charter Communications
CHTR
$17.3B
$489K 0.01%
+750
New +$511K
GPRE icon
630
CALL
Green Plains
GPRE
$1.15B
$487K 0.01%
14,000
ASTS icon
631
CALL
AST SpaceMobile
ASTS
$15.8B
$484K 0.01%
+61,000
New +$626K
TAK icon
632
PUT
Takeda Pharmaceutical
TAK
$56.7B
$477K 0.01%
35,000
ALLY icon
633
CALL
Ally Financial
ALLY
$13.1B
$476K 0.01%
+10,000
New +$495K
BGFV
634
CALL
DELISTED
Big 5 Sporting Goods
BGFV
$475K 0.01%
+25,000
New +$624K
ARKK icon
635
ARK Innovation ETF
ARKK
$5.59B
$473K 0.01%
+5,000
New +$546K
KNSA icon
636
PUT
Kiniksa Pharmaceuticals
KNSA
$6.31B
$471K 0.01%
+40,000
New +$492K
AMRS
637
PUT
DELISTED
Amyris Inc.
AMRS
$470K 0.01%
+86,800
New +$810K
SAN icon
638
PUT
Banco Santander
SAN
$191B
$469K 0.01%
142,500
FISV
639
Fiserv Inc
FISV
$29.7B
$467K 0.01%
+4,500
New +$465K
PLBY icon
640
CALL
Playboy Inc
PLBY
$136M
$466K 0.01%
+17,500
New +$529K
AY
641
PUT
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$465K 0.01%
+13,000
New +$488K
GRPN icon
642
Groupon
GRPN
$1.03B
$463K 0.01%
+20,000
New +$467K
SOFI icon
643
SoFi Technologies
SOFI
$19.6B
$458K 0.01%
+29,000
New +$532K
DOCU
644
CALL
DocuSign
DOCU
$11.1B
$457K 0.01%
3,000
DOCU
645
PUT
DocuSign
DOCU
$11.1B
$457K 0.01%
3,000
IONS icon
646
CALL
Ionis Pharmaceuticals
IONS
$8.93B
$456K 0.01%
15,000
+5,100
+52% +$161K
IONS icon
647
PUT
Ionis Pharmaceuticals
IONS
$8.93B
$456K 0.01%
15,000
URA icon
648
PUT
Global X Uranium ETF
URA
$5.21B
$456K 0.01%
+20,000
New +$528K
MP icon
649
MP Materials
MP
$6.78B
$454K 0.01%
+10,000
New +$394K
JOYY
650
PUT
JOYY Inc
JOYY
$3.73B
$454K 0.01%
+10,000
New +$516K

Similar funds

SG3 Management's Q4 2021 Portfolio in Review

As of Q4 2021, SG3 Management held 1,419 positions worth $4.92B, up 49% from $3.3B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

SG3 Management deployed $1.41B of net new capital in Q4 2021, opening 468 new positions and adding to 176 existing holdings. Its largest new stake was Tesla: 619,500 shares worth $218M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 8.5% of assets, up from 0.74% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Moderna, an estimated $9.79M trimmed.

  • SG3 Management's largest Q4 2021 buy was Tesla: 619,500 shares worth $218M.
  • SG3 Management added most to Amazon in Q4 2021, an estimated $165M increase.
  • SG3 Management's biggest Q4 2021 reduction was Moderna, cutting an estimated $9.79M.
  • SG3 Management fully exited Acceleron Pharma in Q4 2021, selling an estimated $10.3M.
  • SG3 Management's ten largest holdings make up 37% of its $4.92B portfolio in Q4 2021.
  • SG3 Management opened 468 new positions and closed 410 in Q4 2021.
  • SG3 Management's portfolio value rose 49% quarter-over-quarter to $4.92B.

Based on SG3 Management's 13F filing for Q4 2021, filed 15 Feb 2022.